News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
293,639 Results
Type
Article (15107)
Company Profile (112)
Press Release (278412)
Multimedia
Podcasts (65)
Webinars (13)
Section
Business (92479)
Career Advice (551)
Deals (16253)
Drug Delivery (74)
Drug Development (39065)
Employer Resources (53)
FDA (6796)
Job Trends (6727)
News (158097)
Policy (14564)
Tag
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (484)
Accelerated approval (17)
Adcomms (8)
Allergies (78)
Alliances (23903)
ALS (69)
Alzheimer's disease (576)
Antibody-drug conjugate (ADC) (142)
Approvals (7058)
Artificial intelligence (242)
Autoimmune disease (57)
Automation (16)
Bankruptcy (157)
Best Places to Work (4851)
BIOSECURE Act (9)
Biosimilars (131)
Biotechnology (43)
Bladder cancer (80)
Brain cancer (34)
Breast cancer (286)
Cancer (2055)
Cardiovascular disease (206)
Career advice (487)
Career pathing (14)
CAR-T (82)
CDC (6)
Cell therapy (224)
Cervical cancer (17)
Clinical research (34711)
Collaboration (870)
Compensation (582)
Complete response letters (36)
COVID-19 (826)
CRISPR (46)
C-suite (471)
Cystic fibrosis (67)
Data (2827)
Denatured (18)
Depression (56)
Diabetes (192)
Diagnostics (1679)
Digital health (15)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (124)
Drug pricing (118)
Drug shortages (12)
Duchenne muscular dystrophy (119)
Earnings (37632)
Editorial (21)
Employer branding (5)
Employer resources (47)
Events (43074)
Executive appointments (574)
FDA (8292)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (521)
Gene editing (84)
Generative AI (21)
Gene therapy (219)
GLP-1 (486)
Government (1456)
Grass and pollen (4)
Guidances (241)
Healthcare (4170)
HIV (24)
Huntington's disease (13)
IgA nephropathy (42)
Immunology and inflammation (82)
Immuno-oncology (21)
Indications (58)
Infectious disease (913)
Inflammatory bowel disease (84)
Inflation Reduction Act (8)
Influenza (37)
Intellectual property (122)
Interviews (76)
IPO (6456)
IRA (33)
Job creations (2157)
Job search strategy (433)
JPM (30)
Kidney cancer (10)
Labor market (43)
Layoffs (222)
Leadership (9)
Legal (3509)
Liver cancer (28)
Longevity (9)
Lung cancer (280)
Lymphoma (199)
Machine learning (17)
Management (18)
Manufacturing (445)
MASH (92)
Medical device (1986)
Medtech (1998)
Mergers & acquisitions (10348)
Metabolic disorders (562)
Multiple sclerosis (75)
NASH (14)
Neurodegenerative disease (103)
Neuropsychiatric disorders (39)
Neuroscience (1095)
Neurotech (1)
NextGen: Class of 2026 (1823)
Non-profit (676)
Now hiring (25)
Obesity (261)
Opinion (148)
Ovarian cancer (60)
Pain (124)
Pancreatic cancer (88)
Parkinson's disease (108)
Partnered (13)
Patents (245)
Patient recruitment (154)
Peanut (20)
People (30273)
Pharmaceutical (66)
Pharmacy benefit managers (19)
Phase 1 (9300)
Phase 2 (14727)
Phase 3 (13126)
Pipeline (2679)
Policy (139)
Postmarket research (1430)
Preclinical (3657)
Press Release (25)
Prostate cancer (114)
Psychedelics (18)
Radiopharmaceuticals (152)
Rare diseases (429)
Real estate (2731)
Recruiting (19)
Regulatory (11649)
Reports (24)
Research institute (616)
Resumes & cover letters (75)
Rett syndrome (15)
RNA editing (6)
RSV (25)
Schizophrenia (87)
Series A (86)
Series B (59)
Service/supplier (3)
Sickle cell disease (59)
Special edition (17)
Spinal muscular atrophy (83)
Sponsored (13)
Startups (1694)
State (2)
Stomach cancer (6)
Supply chain (54)
Tariffs (68)
The Weekly (45)
Vaccines (281)
Venture capital (34)
Weight loss (164)
Women's health (32)
Worklife (4)
Date
Last 7 days (250)
Last 30 days (949)
Last 365 days (14305)
2026 (1268)
2025 (14669)
2024 (15796)
2023 (15839)
2022 (21101)
2021 (21624)
2020 (20269)
2019 (15926)
2018 (12430)
2017 (14780)
2016 (13720)
2015 (16020)
2014 (12807)
2013 (10820)
2012 (11667)
2011 (12220)
2010 (11143)
Location
Africa (373)
Alabama (23)
Alaska (1)
Arizona (84)
Arkansas (3)
Asia (22081)
Australia (2850)
California (4913)
Canada (1757)
China (637)
Colorado (231)
Connecticut (244)
Delaware (224)
Europe (43379)
Florida (794)
Georgia (110)
Hawaii (1)
Idaho (10)
Illinois (469)
India (47)
Indiana (282)
Iowa (8)
Japan (303)
Kansas (77)
Kentucky (20)
Louisiana (7)
Maine (4)
Maryland (563)
Massachusetts (3724)
Michigan (83)
Minnesota (210)
Mississippi (1)
Missouri (41)
Montana (8)
Nebraska (9)
Nevada (24)
New Hampshire (10)
New Jersey (1695)
New Mexico (7)
New York (1252)
North Carolina (682)
North Dakota (3)
Northern California (2308)
Ohio (118)
Oklahoma (5)
Oregon (20)
Pennsylvania (972)
Puerto Rico (12)
Rhode Island (21)
South America (576)
South Carolina (11)
Southern California (2101)
Tennessee (64)
Texas (665)
United States (17767)
Utah (79)
Virginia (173)
Washington D.C. (45)
Washington State (333)
West Virginia (1)
Wisconsin (71)
Wyoming (1)
293,639 Results for "x4 pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
X4 Pharmaceuticals Announces Closing of Upsized $85 Million Private Placement
August 13, 2025
·
5 min read
Press Releases
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 15, 2025
August 18, 2025
·
3 min read
Press Releases
X4 Pharmaceuticals Announces $60 Million Equity Financing with Concurrent Changes in Management and Board Leadership
August 12, 2025
·
8 min read
Press Releases
X4 Pharmaceuticals Announces Reverse Stock Split
April 24, 2025
·
6 min read
Deals
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 3, 2024
X4 Pharmaceuticals today announced that, effective on May 31, 2024, the company issued inducement awards to new employees under the X4 Pharmaceuticals, Inc.
June 3, 2024
·
1 min read
Press Releases
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 2, 2025
June 3, 2025
·
1 min read
Press Releases
C4X Discovery announces selection of a once-daily development candidate from its α4β7 inhibitor programme
September 22, 2025
·
4 min read
Press Releases
X4 Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates
May 1, 2025
·
15 min read
Press Releases
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 23, 2025
April 24, 2025
·
1 min read
Genetown
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 01, 2024
X4 Pharmaceuticals, a company driven to improve the lives of people with rare diseases of the immune system, announced that, effective on April 30, 2024, the company issued inducement awards to new employees under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan.
May 1, 2024
·
1 min read
1 of 29,364
Next
